Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

CNY 3.83

(-1.03%)

Operating Income Summary of Hubei Biocause Pharmaceutical Co., Ltd.

  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest annual operating income in 2023 was 1.21 Billion CNY , down -96.1% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest quarterly operating income in 2024 Q3 was 163.99 Million CNY , up 155.6% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported an annual operating income of 31.18 Billion CNY in 2022, down -5.25% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported an annual operating income of 32.91 Billion CNY in 2021, up 748.04% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly operating income of -122.18 Million CNY for 2024 Q1, down -110.28% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly operating income of -294.95 Million CNY for 2024 Q2, down -141.41% from previous quarter.

Annual Operating Income Chart of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Historical Annual Operating Income of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Year Operating Income Operating Income Growth
2023 1.21 Billion CNY -96.1%
2022 31.18 Billion CNY -5.25%
2021 32.91 Billion CNY 748.04%
2020 3.88 Billion CNY -67.8%
2019 12.05 Billion CNY 354.21%
2018 2.65 Billion CNY -2.71%
2017 2.72 Billion CNY -20.36%
2016 3.42 Billion CNY 930.97%
2015 332.19 Million CNY 228.69%
2014 101.06 Million CNY 171.62%
2013 -141.1 Million CNY -1046.42%
2012 14.9 Million CNY 113.12%
2011 -113.67 Million CNY -611.59%
2010 22.21 Million CNY -58.23%
2009 53.19 Million CNY 2226.28%
2008 2.28 Million CNY -97.85%
2007 106.43 Million CNY 100.34%
2006 53.12 Million CNY 546.32%
2005 8.21 Million CNY 578.12%
2004 -1.71 Million CNY 96.19%
2003 -45.07 Million CNY -384.58%
2002 15.83 Million CNY -72.44%
2001 57.47 Million CNY 19.04%
2000 48.28 Million CNY 15.6%
1999 41.76 Million CNY 36.02%
1998 30.7 Million CNY -51.32%
1997 63.07 Million CNY 29.81%
1996 48.59 Million CNY 57.88%
1995 30.77 Million CNY 0.0%

Peer Operating Income Comparison of Hubei Biocause Pharmaceutical Co., Ltd.

Name Operating Income Operating Income Difference
COFCO Capital Holdings Co., Ltd. 1.87 Billion CNY 34.976%